Decision Diagnostics Stock Fundamentals
| DECN Stock | USD 0.0001 0.00 0.00% |
Decision Diagnostics fundamentals help investors to digest information that contributes to Decision Diagnostics' financial success or failures. It also enables traders to predict the movement of Decision Stock. The fundamental analysis module provides a way to measure Decision Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Decision Diagnostics stock.
At this time, Decision Diagnostics' Interest Expense is very stable compared to the past year. As of the 2nd of December 2024, Gross Profit is likely to grow to about 774.8 K, while Selling General Administrative is likely to drop about 2.6 M. Decision | Select Account or Indicator |
Decision Diagnostics Company Current Valuation Analysis
Decision Diagnostics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Decision Diagnostics Current Valuation | 3.06 M |
Most of Decision Diagnostics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Decision Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Decision Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Decision Diagnostics is extremely important. It helps to project a fair market value of Decision Stock properly, considering its historical fundamentals such as Current Valuation. Since Decision Diagnostics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Decision Diagnostics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Decision Diagnostics' interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Decision Diagnostics has a Current Valuation of 3.06 M. This is 99.98% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.98% higher than that of the company.
Decision Diagnostics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Decision Diagnostics's current stock value. Our valuation model uses many indicators to compare Decision Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Decision Diagnostics competition to find correlations between indicators driving Decision Diagnostics's intrinsic value. More Info.Decision Diagnostics is rated below average in return on equity category among its peers. It is rated # 5 in return on asset category among its peers . At this time, Decision Diagnostics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Decision Diagnostics' earnings, one of the primary drivers of an investment's value.Decision Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Decision Diagnostics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Decision Diagnostics could also be used in its relative valuation, which is a method of valuing Decision Diagnostics by comparing valuation metrics of similar companies.Decision Diagnostics is currently under evaluation in current valuation category among its peers.
Decision Diagnostics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Decision Diagnostics from analyzing Decision Diagnostics' financial statements. These drivers represent accounts that assess Decision Diagnostics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Decision Diagnostics' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 6.5M | 2.5M | 2.2M | 4.8M | 4.3M | 2.8M | |
| Enterprise Value | 7.5M | 3.7M | 4.9M | 7.1M | 6.4M | 4.0M |
Decision Fundamentals
| Return On Equity | -81.61 | ||||
| Return On Asset | -0.21 | ||||
| Operating Margin | (0.95) % | ||||
| Current Valuation | 3.06 M | ||||
| Shares Outstanding | 357.87 M | ||||
| Price To Earning | (0.33) X | ||||
| Price To Book | 2.72 X | ||||
| Price To Sales | 0.02 X | ||||
| Revenue | 1.98 M | ||||
| Gross Profit | 194.17 K | ||||
| EBITDA | (2.41 M) | ||||
| Net Income | (29.67 M) | ||||
| Cash And Equivalents | 210.85 K | ||||
| Total Debt | 2.93 M | ||||
| Debt To Equity | 9.05 % | ||||
| Current Ratio | 0.25 X | ||||
| Cash Flow From Operations | (1.4 M) | ||||
| Earnings Per Share | (0.02) X | ||||
| Beta | -1.78 | ||||
| Market Capitalization | 35.79 K | ||||
| Total Asset | 5.65 M | ||||
| Retained Earnings | (79.4 M) | ||||
| Working Capital | (3.3 M) | ||||
| Current Asset | 4.3 M | ||||
| Current Liabilities | 3.06 M | ||||
| Net Asset | 5.65 M |
About Decision Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Decision Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Decision Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Decision Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 1.8 M | 1.7 M | |
| Cost Of Revenue | 1.3 M | 1.3 M | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Sales General And Administrative To Revenue | 1.05 | 1.36 | |
| Capex To Revenue | 0.04 | 0.04 | |
| Revenue Per Share | 0.01 | 0.01 | |
| Ebit Per Revenue | (0.96) | (1.01) |
Pair Trading with Decision Diagnostics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Decision Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decision Diagnostics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Decision Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Decision Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Decision Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Decision Diagnostics to buy it.
The correlation of Decision Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Decision Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Decision Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Decision Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Decision Diagnostics Piotroski F Score and Decision Diagnostics Altman Z Score analysis. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 0.006 | Quarterly Revenue Growth (0) | Return On Assets (0.21) | Return On Equity (81.61) |
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.